About this item:

250 Views | 208 Downloads

Author Notes:

Corresponding Authors: Jennifer C. Felger, Ph.D., 1365 Clifton Road, Emory University, Clinic B 5103, Atlanta, GA 30322; fjelger@emory.edu. Or, Zhihao Li, Ph.D., Shenzhen University, 536 Science & Technology Building, 3688 Nanhai Ave, Shenzhen, Guangdong, China 518060; zhihao_li@szu.edu.cn

All authors declare no conflicts of interest and have nothing to disclose.

Subjects:

Research Funding:

This work was supported by funds from the National Institute of Mental Health to JCF (R01MH109637, R21MH106904) and EH (K23MH091254), the Brain and Behavioral Research Foundation and Dana Foundation to JCF (BBRF22296, CADF49143), and from the Natural Science Foundation of China/Shenzhen to ZL (31671169, 31530031/000099).

In addition, the study was supported in part by PHS Grants UL1TR000454 and KL2TR000455 from the Clinical and Translational Science Award program, and by the NIH/NCI under award number P30CA138292.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Neurosciences
  • Psychiatry
  • Neurosciences & Neurology
  • Inflammation
  • Amygdala
  • Functional connectivity
  • fMRI
  • C-reactive protein
  • Anxiety
  • Depression
  • Post-traumatic stress disorder
  • POSTTRAUMATIC-STRESS-DISORDER
  • ELEVATED INFLAMMATION
  • RESPONSES
  • BIOMARKER
  • SICKNESS
  • REWARD
  • WOMEN

Journal Title:

Brain, Behavior, and Immunity

Volume:

Volume 73

Publisher:

, Pages 725-730

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Biomarkers of inflammation, including inflammatory cytokines and the acute-phase reactant C-reactive protein (CRP), are reliably increased in a subset of patients with depression, anxiety disorders and post-traumatic stress disorder (PTSD). Administration of innate immune stimuli to laboratory subjects and the associated release of inflammatory cytokines has been shown to affect brain regions involved in fear, anxiety and emotional processing such as the amygdala. However, the role of inflammation in altered circuitry involving amygdala and other brain regions and its subsequent contribution to symptom severity in depression, anxiety disorders and PTSD is only beginning to be explored. Herein, medically-stable, currently unmedicated outpatients with a primary diagnosis of major depressive disorder (MDD; n = 48) underwent resting-state functional MRI (rfMRI) to determine whether altered connectivity between the amygdala and whole brain was observed in a subset of patients with high inflammation and symptoms of anxiety. Whole-brain, voxel-wise functional connectivity analysis of the right and left amygdala as a function of inflammation (plasma CRP concentrations) revealed that increased CRP predicted decreased functional connectivity between right amygdala and left ventromedial prefrontal cortex (vmPFC) (corrected p < 0.05). Amygdala-vmPFC connectivity was, in turn, negatively correlated with symptoms of anxiety (r = −0.33, df = 46, p = 0.022). In exploratory analyses, relationships between low amygdala-vmPFC connectivity and high anxiety were only observed in patients with a secondary diagnosis of an anxiety disorder or PTSD (r = −0.54 to −0.87, p < 0.05). More work is needed to understand the role of inflammation and its effects on amygdala-vmPFC circuitry and symptoms of anxiety in MDD patients with comorbid anxiety disorders or PTSD.

Copyright information:

© 2018 Elsevier Inc.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote